Dipeptidyl-peptidase 9

Handbook of Proteolytic Enzymes

Volumn 3, Issue , 2013, Pages 3384-3389

  Meester, Ingrid De ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884829394     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382219-2.00747-X     Document Type: Chapter

References (44)

1. Abbott C.A., Yu D.M., Woollatt E., Sutherland G.R., McCaughan G.W., Gorrell M.D. Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur. J. Biochem. 2000, 267(20):6140-6150.
2. Olsen C., Wagtmann N. Identification and characterization of human DPP9, a novel homologue of dipeptidyl peptidase IV. Gene 2002, 299(1-2):185-193.
3. Sedo A., Malik R. Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?. Biochim. Biophys. Acta 2001, 1550(2):107-116.
4. Strop P., Bankovich A.J., Hansen K.C., Garcia K.C., Brunger A.T. Structure of a human A-type potassium channel interacting protein DPPX, a member of the dipeptidyl aminopeptidase family. J. Mol. Biol. 2004, 343(4):1055-1065.
5. Qi S.Y., Riviere P.J., Trojnar J., Junien J.L., Akinsanya K.O. Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases. Biochem. J. 2003, 373(Pt. 1):179-189.
6. Ajami K., Abbott C.A., McCaughan G.W., Gorrell M.D. Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity. Biochim. Biophys. Acta 2004, 1679(1):18-28.
7. Ajami K., Abbott C.A., Obradovic M., Gysbers V., Kahne T., McCaughan G.W., Gorrell M.D. Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family. Biochemistry 2003, 42(3):694-701.
8. Yu D.M., Wang X.M., McCaughan G.W., Gorrell M.D. Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. FEBS J. 2006, 273(11):2447-2460.
9. Park J., Knott H.M., Nadvi N.A., Collyer C.A., Wang X.M., Church W.B., Gorrell M.D. Reversible inactivation of human dipeptidyl peptidases 8 and 9 by oxidation. Open Enzyme Inhibition J. 2008, 1:52-60.
10. Pitman M.R., Sulda M.L., Kuss B., Abbott C.A. Dipeptidyl peptidase 8 and 9-guilty by association?. Frontiers in Bioscience 2009, 14:3619-3633.
11. Dubois V., Lambeir A.-M., Vandamme S., Matheeussen V., Guisez Y., Scharpé S., De Meester I. Dipeptidyl peptidase 9 (DPP9) from bovine testes: identification and characterization as the short form by mass spectrometry. Biochim. Biophys. Acta 2010, 1804:781-788.
12. Bjelke J.R., Christensen J., Nielsen P.F., Branner S., Kanstrup A.B., Wagtmann N., Rasmussen H.B. Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV. Biochem. J. 2006, 396(2):391-399.
13. Ajami K., Pitman M.R., Wilson C.H., Park J., Menz R.I., Starr A.E., Cox J.H., Abbott C.A., Overall C.M., Gorrell M.D. Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8. FEBS Lett. 2008, 582(5):819-825.
14. Tang H.K., Tang H.Y., Hsu S.C., Chu Y.R., Chien C.H., Shu C.H., Chen X. Biochemical properties and expression profile of human prolyl dipeptidase DPP9. Arch. Biochem. Biophys. 2009, 485(2):120-127.
15. Rummey C., Metz G. Homology models of dipeptidyl peptidases 8 and 9 with a focus on loop predictions near the active site. Proteins 2007, 66(1):160-171.
16. Nadvi N.A., Yu D.M.T., Park J., Wang X.M., Osborne B., Collyer C.A., Church W.B., Gorrell M.D. Tolerating tags in the DPIV family. Clin. Chem. Lab. Med. 2008, 46(4):A11.
17. Dubois V., Lambeir A.-M., Van der Veken P., Augustyns K., Creemers J., Chen X., Scharpé S., De Meester I. Purification and characterization of a dipeptidyl peptidase 9-like enzyme from bovine testes. Front Biosci. 2008, 13:3558-3568.
18. Geiss-Friedlander R., Parmentier N., Moeller U., Urlaub H., Van den Eynde B.J., Melchior F. The cytoplasmic peptidase DPP9 is rate-limiting for degradation of proline-containing peptides. J. Biol. Chem. 2009, 284(40):27211-27219.
19. Maes M.B., Dubois V., Brandt I., Lambeir A.-M., Van der Veken P., Augustyns K., Cheng J.D., Chen X., Scharpé S., De Meester I. Dipeptidyl peptidase 8/9-like activity in human leukocytes. J. Leukoc. Biol. 2007, 81(5):1252-1257.
20. Matheeussen V., Baerts L., De Meyer G., De Keulenaer G., Van der Veken P., Augustyns K., Dubois V., Scharpé S., De Meester I. Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries. Biol. Chem. 2011, 392:189-198.
21. Lankas G.R., Leiting B., Roy R.S., Eiermann G.J., Beconi M.G., Biftu T., Chan C.C., Edmondson S., Feeney W.P., He H., Ippolito D.E., Kim D., Lyons K.A., Ok H.O., Patel R.A., Petrov A.N., Pryor K.A., Qian X., Reigle L., Woods A., Wu J.K., Zaller D., Zhang X., Zhu L., Weber A.E., Thornberry N.A. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9. Diabetes 2005, 54(10):2988-2994.
22. Reinhold D, Goihl A., Wrenger S., Reinhold A., Kuhlmann U.C., Faust J., Neubert K., Thielitz A., Brocke S., Tager M., Ansorge S., Bank U. Review: Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice. Clin. Chem. Lab. Med. 2009, 47(3):268-274.
23. Van der Veken P., Haemers A., Augustyns K. Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery. Curr. Top. Med. Chem. 2007, 7(6):621-635.
24. Van der Veken P., De Meester I., Dubois V., Soroka A., Van Goethem S., Maes M.B., Brandt I., Lambeir A.-M., Chen X., Haemers A., Scharpé S., Augustyns K. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads. Bioorg. Med. Chem. Lett. 2008, 18(14):4154-4158.
25. Jiaang W.T., Chen Y.S., Hsu T., Wu S.H., Chien C.H., Chang C.N., Chang S.P., Lee S.J., Chen X. Novel isoindoline compounds for potent and selective inhibition of prolyl dipeptidase DPP8. Bioorg. Med. Chem. Lett. 2005, 15(3):687-691.
26. Wu J.J., Tang H.K., Yeh T.K., Chen C.M., Shy H.S., Chu Y.R., Chien C.H., Tsai T.Y., Huang Y.C., Huang Y.L., Huang C.H., Tseng H.Y., Jiaang W.T., Chao Y.S., Chen X. Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor. Biochem. Pharmacol. 2009, 78(2):203-210.
27. Van Goethem S., Van der Veken P., Dubois V., Soroka A., Lambeir A.-M., Chen X., Haemers A., Scharpé S., De Meester I., Augustyns K. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors. Bioorg. Med. Chem. Lett. 2008, 18(14):4159-4162.
28. Van der Veken P., Soroka A., Brandt I., Chen Y.S., Maes M.B., Lambeir A.-M., Chen X., Haemers A., Scharpé S., Augustyns K., De Meester I. Irreversible inhibition of dipeptidyl peptidase 8 by dipeptide-derived diaryl phosphonates. J. Med. Chem. 2007, 50(23):5568-5570.
29. Frerker N., Wagner L., Wolf R., Heiser U., Hoffmann T., Rahfeld J.U., Schade J., Karl T., Naim H.Y., Alfalah M., Demuth H.U., von Horsten S. Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4. Peptides 2007, 28(2):257-268.
30. Wagner L., Hoffmann T., Rahfeld J.U., Demuth H.U. Distribution of dipeptidyl peptidase IV-like activity enzymes in canine and porcine tissue sections by RT-PCR. Adv. Exp. Med. Biol. 2006, 575:109-116.
31. Helmuth M., Reinhold D., Stefin S., Täger M., Ansorge S., Bank U. Tissue distribution of DPIV-like activities in wild type mice and CD26 knock out mice under physiological and pathological conditions. Clin. Chem. Lab. Med. 2008, 46(4):A26.
32. Ansorge S., Bank U., Heimburg A., Helmuth M., Koch G., Tadje J., Lendeckel U., Wolke C., Neubert K., Faust J., Fuchs P., Reinhold D., Thielitz A., Tager M. Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions. Clin. Chem. Lab. Med. 2009, 47(3):253-261.
33. Wagner L., Gündel D., Zeitschel U., Rossner S., Frerker N., Schade J., Stiller J., Niestroj A., Thümmler A., Wolf R., Gärtner U.T., Manhart S., Kehlen A., Rahfeld J.U., Hoffmann T., von Hörsten S., Demuth H.U. Tissue-distribution of dipeptidyl peptidase 4-like enzymes in distinct brain areas and neuronal tissues. Clin. Chem. Lab. Med. 2008, 46(4):A11.
34. Yu D.M., Ajami K., Gall M.G., Park J., Lee C.S., Evans K.A., McLaughlin E.A., Pitman M.R., Abbott C.A., McCaughan G.W., Gorrell M.D. The in vivo expression of dipeptidyl peptidases 8 and 9. J. Histochem. Cytochem. 2009, 57(11):1025-1040.
35. Dubois V., Van Ginneken C., De Cock H., Lambeir A.-M., Van der Veken P., Augustyns K., Chen X., Scharpé S., De Meester I. Enzyme activity and immunohistochemical localization of dipeptidyl peptidase 8 and 9 in male reproductive tissues. J. Histochem. Cytochem. 2009, 57:531-541.
36. Tadje J., Heimburg A., Koch G., Helmuth M., Reinhold D., Fuchs P., Faust J., Neubert K., Täger M., Ansorge S., Bank U. Expression pattern and inhibition of DASH proteins in T cell subsets and related cell lines. Clin. Chem. Lab. Med. 2008, 46(4):A36.
37. Heimburg A., Reinhold D., Faust J., Fuchs P., Neubert K., Täger M., Ansorge S., Bank U. Differential expression of DPIV-like enzymes during the course of T cell activation. Clin. Chem. Lab. Med. 2008, 46(4):A12.
38. Schade J., Stephan M., Schmiedl A., Wagner L., Niestroj A.J., Demuth H.U., Frerker N., Klemann C., Raber K.A., Pabst R., von Horsten S. Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8/9, and DP10 in allergic responses of the lung in rats. J. Histochem. Cytochem. 2008, 56(2):147-155.
39. Milner J., Hui W., Davidson R., Gilmore B., Walker B., Clark I., Rowan D. Inhibition of FAP and dipeptidyl peptidase enzymes blocks cartilage resorption. Clin. Chem. Lab. Med. 2008, 46(4):A31.
40. Thielitz A., Vetter R.W., Schultze B., Wrenger S., Simeoni L., Ansorge S., Neubert K., Faust J., Lindenlau P., Gollnick H.P., Reinhold D. Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts. J. Invest. Dermatol. 2008, 128(4):855-866.
41. Rosenblum J.S., Kozarich J.W. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Curr. Opin. Chem. Biol. 2003, 7(4):496-504.
42. De Meester I., Scharpé S., Lambeir A.M. Dipeptidyl peptidases and related proteins: multifaceted markers and therapeutic targets. Clin. Chem. Lab. Med. 2009, 47(3):245-247.
43. Busek P., Stremenova J., Sedo A. Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors - good or evil?. Front Biosci. 2008, 13:2319-2326.
44. Yazbeck R., Howarth G.S., Abbott C.A. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?. Trends Pharmacol. Sci. 2009, 30:600-607.